| Tumor microenvironment heterogeneity: challenges and opportunities F Runa, S Hamalian, K Meade, P Shisgal, PC Gray, JA Kelber Current molecular biology reports 3, 218-229, 2017 | 146 | 2017 |
| Ulocladium systematics revisited: phylogeny and taxonomic status F Runa, MS Park, BM Pryor Mycological progress 8, 35-47, 2009 | 71 | 2009 |
| Identification of a PEAK1/ZEB1 signaling axis during TGFβ/fibronectin-induced EMT in breast cancer M Agajanian, F Runa, JA Kelber Biochemical and biophysical research communications 465 (3), 606-612, 2015 | 47 | 2015 |
| Nuclear heterogeneity in conidial populations of Aspergillus flavus F Runa, I Carbone, D Bhatnagar, GA Payne Fungal genetics and biology 84, 62-72, 2015 | 20 | 2015 |
| Molecular versus conventional methods: clinical evaluation of different methods for the diagnosis of tuberculosis in Bangladesh F Runa, M Yasmin, MM Hoq, J Begum, ASMM Rahman, CR Ahsan Journal of Microbiology, Immunology and Infection 44 (2), 101-105, 2011 | 18 | 2011 |
| A SNAI2-PEAK1-INHBA stromal axis drives progression and lapatinib resistance in HER2-positive breast cancer by supporting subpopulations of tumor cells positive for … S Hamalian, R Güth, F Runa, F Sanchez, E Vickers, M Agajanian, ... Oncogene 40 (33), 5224-5235, 2021 | 12 | 2021 |
| Identification of myosin II as a cripto binding protein and regulator of cripto function in stem cells and tissue regeneration M Hoover, F Runa, E Booker, JK Diedrich, E Duell, B Williams, ... Biochemical and biophysical research communications 509 (1), 69-75, 2019 | 11 | 2019 |
| Ascending the PEAK1 toward targeting TGFβ during cancer progression: recent advances and future perspectives F Runa, Y Adamian, JA Kelber Cancer cell & microenvironment 3 (1), 2016 | 9 | 2016 |
| Impact of COVID-19 pandemic on rare diseases-A case study on thalassaemia patients in Bangladesh MS Hossain, F Runa, A Al Mosabbir Public Health in Practice 2, 100150, 2021 | 8 | 2021 |
| Tumor microenvironment heterogeneity: challenges and opportunities. Curr Mol Biol Rep. 2017; 3 (4): 218–29 F Runa, S Hamalian, K Meade, P Shisgal, PC Gray, JA Kelber Epub 2018/02/13. doi: 10.1007/s40610-017-0073-7. PubMed PMID: 29430386, 0 | 4 | |
| Fibronectin, DHPS and SLC3A2 Signaling Cooperate to Control Tumor Spheroid Growth, Subcellular EIF5A1/2 Distribution and CDK4/6 Inhibitor Resistance C Geller, J Maddela, R Tuplano, F Runa, Y Adamian, R Güth, GO Soto, ... bioRxiv, 2023 | 3 | 2023 |
| Nuclear condition in Aspergillus flavus during growth and conidiation F Runa, I Carbone, GA Payne Genetics of Maize Disease Workshop, 20-23, 2011 | 2 | 2011 |
| Targeting SMAD-Dependent Signaling: Considerations in Epithelial and Mesenchymal Solid Tumors. F Runa, G Ortiz-Soto, NR de Barros, JATSDSCEMST Kelber Pharmaceuticals 13 (3), 326, 2024 | 1 | 2024 |
| Patient‐Derived Organoids as Therapy Screening Platforms in Cancer Patients D Khorsandi, JW Yang, S Foster, S Khosravi, ... Advanced Healthcare Materials, 2302331, 2024 | 1 | 2024 |
| Abstract PO5-24-04: Fibronectin, DHPS and SLC3A2 Signaling Cooperate to Control Tumor Spheroid Growth, Subcellular eIF5A1/2 Distribution and CDK4/6 Inhibitor Resistance C Geller, J Maddela, G Ortiz-Soto, R Tuplano, F Runa, Y Adamian, R Güth, ... Cancer Research 84 (9_Supplement), PO5-24-04-PO5-24-04, 2024 | | 2024 |
| Multidimensional screening of pancreatic cancer spheroids reveals vulnerabilities in mitotic and cell-matrix adhesion signaling that associate with metastatic progression and … AF Aquino, F Runa, JF Shoma, A Todd, M Wallace, NR de Barros, ... Biochemical and biophysical research communications 703, 149575, 2024 | | 2024 |
| Retinoic acid induced 14 drives pancreatic cancer progression and metastasis F Runa, L Tomaneng, Y Adamian, N Cox, AF Aquino, M Wallace, ... Cancer Research 82 (12_Supplement), 2414-2414, 2022 | | 2022 |
| Impact of COVID-19 pandemic on rare diseases-A case study on thalassaemia patients in Bangladesh (preprint) MS Hossain, F Runa, A Al Mosabbir | | 2021 |
| A SNAI2-PEAK1 stromal axis drives progression and lapatinib resistance in HER2-positive breast cancer by supporting a cytokine expression profile that converges on PI3K/Akt … S Hamalian, R Güth, F Runa, J Molnar, E Vickers, M Agajanian, ... bioRxiv, 2020.05. 15.098772, 2020 | | 2020 |
| CSUNPOSIUM A STUDENT | | 2019 |
Jonathan KelberBaylor UniversityVerified email at baylor.edu
